- Home
- HUM vs BNTX Comparison
HUM vs BNTX Comparison
Compare HUM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUM
- BNTX
- Stock Information
- Founded
- HUM 1961
- BNTX 2008
- Country
- HUM United States
- BNTX Germany
- Employees
- HUM N/A
- BNTX N/A
- Industry
- HUM Medical Specialities
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUM Health Care
- BNTX Health Care
- Exchange
- HUM Nasdaq
- BNTX Nasdaq
- Market Cap
- HUM 29.9B
- BNTX 25.0B
- IPO Year
- HUM 1993
- BNTX 2019
- Fundamental
- Price
- HUM $230.60
- BNTX $108.49
- Analyst Decision
- HUM Hold
- BNTX Strong Buy
- Analyst Count
- HUM 21
- BNTX 18
- Target Price
- HUM $282.95
- BNTX $141.94
- AVG Volume (30 Days)
- HUM 2.0M
- BNTX 1.2M
- Earning Date
- HUM 07-30-2025
- BNTX 08-04-2025
- Dividend Yield
- HUM 1.53%
- BNTX N/A
- EPS Growth
- HUM N/A
- BNTX N/A
- EPS
- HUM 14.16
- BNTX N/A
- Revenue
- HUM $120,262,000,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- HUM $8.72
- BNTX N/A
- Revenue Next Year
- HUM $2.88
- BNTX $7.16
- P/E Ratio
- HUM $16.28
- BNTX N/A
- Revenue Growth
- HUM 10.09
- BNTX 0.61
- 52 Week Low
- HUM $212.45
- BNTX $76.53
- 52 Week High
- HUM $406.46
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- HUM 42.52
- BNTX 57.16
- Support Level
- HUM $225.85
- BNTX $93.50
- Resistance Level
- HUM $236.56
- BNTX $122.90
- Average True Range (ATR)
- HUM 7.29
- BNTX 4.42
- MACD
- HUM 0.58
- BNTX 1.51
- Stochastic Oscillator
- HUM 27.52
- BNTX 50.99
About HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.